Bettapharma mainly providing customers with products such as Ectinib hydrochlorid
Beda Pharmaceuticals is an innovative drug developer in the fields of malignancy, ophthalmology, autoimmune diseases and diabetes, mainly providing customers with products such as Ectinib hydrochloride (Kemena), new antineoplastic drug CM082 and other products, including six national Class I and Class II new drugs, and 14 national Class III and Class IV new drugs in the pipeline.
EqualOcean Sector Quarterly Report - Healthcare Sectors
To help worldwide investors keep track of what is happening in each industry or sector and the related hot spots, we launched the EqualOcean Sector Quarterly Report series, which gathers notable information and statistics in each quarter.
Apr 07, 2022 01:44 PM
ResearchHealthcare, Consumer Staples, Technology
WIA2020 | Rising Tech Stars 2020: Global & China's 100
ResearchHealthcare, Technology, Consumer Discretionary
Tech for Global, Globalization Footprints of the Established and the New
Cell Therapy Developer Senlang Bio Raises CNY 200 Million in New Funding Round
Founded in 2016, Hebei Senlang Bio is a clinical-stage biotechnology company dedicated to utilizing cell and gene engineering technologies to generate innovative and transformative cellular immunotherapies for solid and hematologic cancers.
May 18, 2022 01:00 PM